Pediatrix Medical Group, Inc.

65
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US58502B1061
USD
21.19
0.59 (2.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Pediatrix Medical Group, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
216.00
-101.00
-48.00
81.00
135.00
7.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
41.00
88.00
-11.00
31.00
-23.00
52.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
271.00
206.00
137.00
166.00
76.00
204.00
Cash Flow from Investing Activities
-18.00
-35.00
-48.00
-56.00
-53.00
815.00
Cash Flow from Financing Activities
-107.00
-14.00
-25.00
-487.00
-760.00
-4.00
Net Cash Inflow / Outflow
145.00
156.00
63.00
-377.00
-736.00
1,015.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Pediatrix Medical Group, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
216.432
-241.364
457.00
189.67%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
41.826
-41.18
82.00
201.57%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
271.091
-178.542
449.00
251.84%
Cash Flow from Investing Activities
-18.296
230.296
-248.00
-107.94%
Cash Flow from Financing Activities
-107.494
-118.056
11.00
8.95%
Net Cash Inflow / Outflow
145.301
-62.873
207.00
331.10%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
3.429
-3.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 31.23% vs 50.43% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
271.09
206.57
31.23%